Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.850
+0.050 (2.78%)
At close: Apr 28, 2026, 4:00 PM EDT
1.805
-0.045 (-2.44%)
Pre-market: Apr 29, 2026, 7:12 AM EDT
Serina Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 3.06 | 3.67 | 7.62 | 0.53 | 0.31 |
| Short-Term Investments | - | - | - | - | 1 |
| Cash & Short-Term Investments | 3.06 | 3.67 | 7.62 | 0.53 | 1.31 |
| Cash Growth | -16.78% | -51.80% | 1331.53% | -59.41% | - |
| Receivables | - | - | - | - | 0 |
| Prepaid Expenses | 0.99 | 1.93 | - | 0.02 | 0.02 |
| Other Current Assets | 2.03 | 0.08 | - | - | - |
| Total Current Assets | 6.08 | 5.68 | 7.62 | 0.55 | 1.33 |
| Property, Plant & Equipment | 0.84 | 1.05 | 1.35 | 0.31 | 0.51 |
| Other Long-Term Assets | 0.03 | - | - | - | - |
| Accounts Payable | 1.93 | 0.74 | 0.58 | 0.14 | 0.15 |
| Accrued Expenses | 1.21 | 1.43 | 0.58 | 0.01 | 0.01 |
| Current Portion of Leases | 0.18 | - | 0.25 | 0.13 | 0.21 |
| Current Unearned Revenue | - | - | - | 0.15 | - |
| Other Current Liabilities | 0.24 | 0.19 | - | 0.01 | 0 |
| Total Current Liabilities | 3.56 | 2.37 | 1.41 | 0.44 | 0.37 |
| Long-Term Debt | 2.95 | - | 2.98 | 1.62 | - |
| Long-Term Leases | 0.2 | 0.27 | 0.46 | 0.06 | 0.19 |
| Other Long-Term Liabilities | 0.28 | 3.58 | - | 1.08 | 0.95 |
| Common Stock | 0 | 0 | - | 0.02 | 0.02 |
| Additional Paid-In Capital | 58.54 | 44.96 | 0.88 | 0.65 | 0.64 |
| Retained Earnings | -63.5 | -44.32 | -33.18 | -38.45 | -35.76 |
| Comprehensive Income & Other | -0.01 | - | - | - | - |
| Total Common Equity | -4.98 | 0.64 | -32.29 | -37.78 | -35.11 |
| Minority Interest | - | -0.13 | - | - | - |
| Total Liabilities & Equity | 6.95 | 6.72 | 8.97 | 0.86 | 1.84 |
| Total Debt | 3.32 | 0.27 | 3.7 | 1.81 | 0.4 |
| Net Cash (Debt) | -0.27 | 3.4 | 3.92 | -1.28 | 0.91 |
| Net Cash Growth | - | -13.25% | - | - | - |
| Net Cash Per Share | -0.03 | 0.46 | 0.53 | -0.60 | 0.43 |
| Filing Date Shares Outstanding | 12.31 | 9.93 | 8.79 | 2.22 | 2.14 |
| Total Common Shares Outstanding | 10.77 | 9.42 | 2.47 | 2.22 | 2.14 |
| Working Capital | 2.52 | 3.31 | 6.21 | 0.11 | 0.96 |
| Book Value Per Share | -0.46 | 0.07 | -13.09 | -17.03 | -16.37 |
| Tangible Book Value | -4.98 | 0.64 | -32.29 | -37.78 | -35.11 |
| Tangible Book Value Per Share | -0.46 | 0.07 | -13.09 | -17.03 | -16.37 |
| Machinery | 0.88 | 0.97 | 0.87 | 0.38 | 0.37 |
Source: S&P Capital IQ. Standard template.
Financial Sources.